HAVCR2 and nasopharyngeal carcinoma: Subsequently, we analyzed the prognosis of patients grouped by age median and found that TIM-3/TIGIT and TIM-3/2B4 co-expression was associated with PFS in NPC patients aged ≥ 52 years (both P < 0.05), which was not seen in patients aged < 52 years.